Europe — EMA
Nadolol Neon Healthcare
GNH USA supplies Nadolol Neon Healthcare (Nadolol), a beta blocker for hypertension, angina and cardiac arrhythmias. Request a quote for global supply.
Request sourcing
What is Nadolol?
Nadolol, the active ingredient in Nadolol Neon Healthcare, is a non‑selective beta blocker presented as an oral formulation for systemic use. It reduces heart rate and myocardial contractility, thereby lowering blood pressure and relieving chest pain, and is employed in the long‑term management of hypertension, angina pectoris, post‑myocardial infarction prophylaxis, and selected cardiac arrhythmias.
GNH USA supplies Nadolol Neon Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.
What is Nadolol used for?
Nadolol is a non‑selective beta‑adrenergic antagonist used in cardiovascular disease management. - Hypertension: lowers blood pressure by decreasing cardiac output and renin release. - Angina pectoris: reduces myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction prophylaxis: helps prevent recurrent ischemic events. - Cardiac arrhythmias: stabilizes heart rhythm in certain supraventricular and ventricular arrhythmias.
What are the side effects of Nadolol?
Nadolol may be associated with a range of adverse reactions, varying in frequency and severity.
Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially on standing. - Gastrointestinal upset: nausea or abdominal discomfort.
Serious or Rare Side Effects: - Bradycardia: excessively slow heart rate. - Bronchospasm: airway tightening, may worsen asthma. - Severe allergic reaction: rash, swelling, or anaphylaxis.
What precautions apply to Nadolol?
When prescribing Nadolol, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiovascular status: evaluate heart rate and blood pressure before initiation. - Monitor renal function: dose adjustment may be needed in renal impairment. - Caution in asthma or COPD: non‑selective blockade can provoke bronchospasm. - Review concomitant medications: avoid combining with other beta‑blockers or calcium channel blockers without supervision. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.
What does Nadolol interact with?
Nadolol can interact with other medicines, altering its efficacy or safety profile.
Major Interactions (Avoid): - Combined use with other beta‑blockers: may cause excessive bradycardia or hypotension. - Concomitant calcium channel blockers (e.g., verapamil, diltiazem): increase risk of heart block.
Moderate Interactions (Monitor Closely): - Antidiabetic agents: beta‑blockade may mask hypoglycemia symptoms. - NSAIDs: may reduce antihypertensive effect. - Antidepressants (e.g., SSRIs): potential for additive bradycardia. - Inhaled bronchodilators: may reduce bronchodilator response.



